FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285514334> ?p ?o ?g. }

• W4285514334 endingPage "37" @default.
• W4285514334 startingPage "32" @default.
• W4285514334 abstract "Introduction: Nilotinib is effective in patients with chronic myeloid leukemia (CML), but is also associated with hyperlipidemia, which can be a risk factor for atherosclerotic vascular events. Objective: To determine the completeness in monitoring the fasting lipid profile (FLP), changes in lipid levels before and after the initiation of nilotinib, and changes in lipid levels after statin therapy. Method: This was a retrospective cohort study that included all patients with CML in the chronic or accelerated phase, who were receiving follow up under the haematology clinic of a regional referral hospital in the state of Perak, Malaysia. Patients who had been prescribed nilotinib from the beginning of January 2010 to June 2020 were included in the study, including patients who were still on treatment as well as those who, despite having their treatment discontinued during the observation period, still followed up in the clinic. The monitoring of FLP was defined as either “complete” (with both pre-initiation and post-initiation FLP available); or “incomplete” (with either one of pre-initiation or post-initiation FLP available); or “not ordered”. An LDL level of ≥ 2.6 mmol / L was considered suboptimal. Since the changes in FLP parameters were found to not be normally distributed, the data were evaluated using the Wilcoxon test, whereby a two-tailed p-value of P < 0.05 was considered statistically significant. Result: 61 patients who met the inclusion criteria were included. The FLP test was not ordered in 16 patients, incomplete in 33 patients and complete in 11 patients (18%). Patients who had completed the test displayed a significant increase in median HDL, LDL, and total cholesterol level from 1.27 to 1.46 mmol / L (p = 0.009), 2.10 to 3.30 mmol / L (p = 0.003) and 3.90 to 5.33 mmol / L (p = 0.005) respectively after the initiation of nilotinib. Statin was prescribed to 6 patients with a baseline mean LDL of 4.77 mmol / L, whereby the mean LDL was significantly reduced by 1.82 mmol / L (p = 0.003) after treatment. Conclusion: Patients experienced a significant increase in total cholesterol and LDL levels with nilotinib. Treatment with statin has elicited a significant reduction in LDL. Only a small proportion of patients received complete FLP monitoring, which warrants attention from the health authority." @default.
• W4285514334 created "2022-07-16" @default.
• W4285514334 creator A5045520388 @default.
• W4285514334 creator A5055789543 @default.
• W4285514334 creator A5061533821 @default.
• W4285514334 date "2022-06-01" @default.
• W4285514334 modified "2023-09-28" @default.
• W4285514334 title "hyperlipidemia-post-initiation-of-nilotinib-among-chronic-myeloid-leukemia-patients-in-a-tertiary-hospital-of-malaysia" @default.
• W4285514334 cites W1535043470 @default.
• W4285514334 cites W188630774 @default.
• W4285514334 cites W1939978733 @default.
• W4285514334 cites W1987045819 @default.
• W4285514334 cites W2015788322 @default.
• W4285514334 cites W2016086822 @default.
• W4285514334 cites W2028959752 @default.
• W4285514334 cites W2057718276 @default.
• W4285514334 cites W2072834954 @default.
• W4285514334 cites W2107268345 @default.
• W4285514334 cites W2138494642 @default.
• W4285514334 cites W2140201096 @default.
• W4285514334 cites W2147124043 @default.
• W4285514334 cites W2260921597 @default.
• W4285514334 cites W2339658711 @default.
• W4285514334 cites W2766247589 @default.
• W4285514334 cites W2978567994 @default.
• W4285514334 cites W3041760231 @default.
• W4285514334 doi "https://doi.org/10.52494/mwvw1554" @default.
• W4285514334 hasPublicationYear "2022" @default.
• W4285514334 type Work @default.
• W4285514334 citedByCount "0" @default.
• W4285514334 crossrefType "journal-article" @default.
• W4285514334 hasAuthorship W4285514334A5045520388 @default.
• W4285514334 hasAuthorship W4285514334A5055789543 @default.
• W4285514334 hasAuthorship W4285514334A5061533821 @default.
• W4285514334 hasBestOaLocation W42855143341 @default.
• W4285514334 hasConcept C126322002 @default.
• W4285514334 hasConcept C134018914 @default.
• W4285514334 hasConcept C167135981 @default.
• W4285514334 hasConcept C2776839432 @default.
• W4285514334 hasConcept C2777413986 @default.
• W4285514334 hasConcept C2777583451 @default.
• W4285514334 hasConcept C2778729363 @default.
• W4285514334 hasConcept C2779091943 @default.
• W4285514334 hasConcept C555293320 @default.
• W4285514334 hasConcept C71924100 @default.
• W4285514334 hasConceptScore W4285514334C126322002 @default.
• W4285514334 hasConceptScore W4285514334C134018914 @default.
• W4285514334 hasConceptScore W4285514334C167135981 @default.
• W4285514334 hasConceptScore W4285514334C2776839432 @default.
• W4285514334 hasConceptScore W4285514334C2777413986 @default.
• W4285514334 hasConceptScore W4285514334C2777583451 @default.
• W4285514334 hasConceptScore W4285514334C2778729363 @default.
• W4285514334 hasConceptScore W4285514334C2779091943 @default.
• W4285514334 hasConceptScore W4285514334C555293320 @default.
• W4285514334 hasConceptScore W4285514334C71924100 @default.
• W4285514334 hasIssue "1" @default.
• W4285514334 hasLocation W42855143341 @default.
• W4285514334 hasLocation W42855143342 @default.
• W4285514334 hasOpenAccess W4285514334 @default.
• W4285514334 hasPrimaryLocation W42855143341 @default.
• W4285514334 hasRelatedWork W1974135663 @default.
• W4285514334 hasRelatedWork W2001925505 @default.
• W4285514334 hasRelatedWork W2010208202 @default.
• W4285514334 hasRelatedWork W2060584185 @default.
• W4285514334 hasRelatedWork W2072665415 @default.
• W4285514334 hasRelatedWork W2740573023 @default.
• W4285514334 hasRelatedWork W2935865435 @default.
• W4285514334 hasRelatedWork W3029333268 @default.
• W4285514334 hasRelatedWork W4281723722 @default.
• W4285514334 hasRelatedWork W4304891595 @default.
• W4285514334 hasVolume "8" @default.
• W4285514334 isParatext "false" @default.
• W4285514334 isRetracted "false" @default.
• W4285514334 workType "article" @default.